Hennion & Walsh Asset Management Inc. Grows Holdings in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Hennion & Walsh Asset Management Inc. boosted its holdings in Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report) by 11.9% in the 4th quarter, Holdings Channel reports. The firm owned 105,343 shares of the company’s stock after purchasing an additional 11,161 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Crescent Capital BDC were worth $2,025,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Point72 Asset Management L.P. purchased a new stake in Crescent Capital BDC in the 2nd quarter valued at $90,000. XTX Topco Ltd acquired a new position in Crescent Capital BDC in the 2nd quarter valued at $195,000. Cubist Systematic Strategies LLC acquired a new position in Crescent Capital BDC in the 2nd quarter valued at $346,000. Pettinga Financial Advisors LLC increased its stake in Crescent Capital BDC by 95.8% in the 3rd quarter. Pettinga Financial Advisors LLC now owns 29,017 shares of the company’s stock valued at $537,000 after buying an additional 14,200 shares during the period. Finally, Redhawk Wealth Advisors Inc. acquired a new position in Crescent Capital BDC in the 4th quarter valued at $659,000. Hedge funds and other institutional investors own 49.46% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on CCAP shares. LADENBURG THALM/SH SH started coverage on shares of Crescent Capital BDC in a research note on Monday, September 30th. They issued a “buy” rating and a $20.00 price objective on the stock. Keefe, Bruyette & Woods boosted their price objective on shares of Crescent Capital BDC from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Monday, November 25th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $19.17.

Check Out Our Latest Report on CCAP

Crescent Capital BDC Stock Performance

NASDAQ:CCAP opened at $19.34 on Friday. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.14. Crescent Capital BDC, Inc. has a fifty-two week low of $15.91 and a fifty-two week high of $20.03. The stock has a market cap of $716.78 million, a PE ratio of 7.58 and a beta of 0.81. The firm’s fifty day simple moving average is $19.27 and its 200-day simple moving average is $18.76.

Crescent Capital BDC Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Tuesday, December 31st were paid a dividend of $0.42 per share. The ex-dividend date was Tuesday, December 31st. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.69%. Crescent Capital BDC’s dividend payout ratio is 65.88%.

About Crescent Capital BDC

(Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Further Reading

Want to see what other hedge funds are holding CCAP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Crescent Capital BDC, Inc. (NASDAQ:CCAPFree Report).

Institutional Ownership by Quarter for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.